Axo Longevity — Company Profile & Funding History

Product and customers

Members complete blood and urine testing through accredited partner laboratories. Axo turns more than 100 biomarkers into an explained health dashboard, tracks results over time and provides an individual action plan and ongoing AI-supported guidance.

The service is operating through a network of partner laboratories and offers recurring six-month testing cycles in several European markets.

Headquarters: London

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Sep 16, 2026	Seed	$5M	51 Ventures — ParticipantCistern Capital — ParticipantDaniel Kulle — ParticipantDr. Jorge Planas — ParticipantEverywhere Ventures — ParticipantIzou Partners — ParticipantLifeX Ventures — ParticipantMS&AD Ventures — ParticipantNIAN Sports & Entertainment — ParticipantUNQ — Participant

Investors

51 VenturesJoined Seed Cistern CapitalJoined Seed Daniel KulleJoined Seed Dr. Jorge PlanasJoined Seed Everywhere VenturesJoined Seed Izou PartnersJoined Seed LifeX VenturesJoined Seed MS&AD VenturesJoined Seed NIAN Sports & EntertainmentJoined Seed UNQJoined Seed

Coverage

Sep 16, 2026Axo Longevity · Seed

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed

CureBayCureBay operates a hybrid healthcare network for rural and underserved communities in India.~₹1B · Pre-Series C

iCUREXKagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.¥140M · Series A first close: equity and debt

Sources

axolongevity.com ↗axolongevity.com ↗